Deep Visual Proteomics maps proteotoxicity in a genetic liver disease.

Florian A Rosenberger1, Sophia C Mädler2, Katrine Holtz Thorhauge3,4

  • 1Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany. rosenberger@biochem.mpg.de.

Nature
|April 16, 2025
PubMed
Summary

This study reveals key molecular events in alpha-1-antitrypsin deficiency (AATD) using advanced proteomics. It identifies early peroxisomal changes and a distinct late-stage cell phenotype, offering new insights into protein misfolding diseases.